Logos Global Management LP
CIK 1792126 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $2.3B
- Posisi
- 68
- Per tanggal
- 30 Juni 2026
#1.378 dari 9.443 berdasarkan nilai 13F · top 14.6%
Nilai portofolio QoQ: +16.0% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 48,35%
- Bobot 25 kepemilikan teratas
- 77,69%
- Posisi di atas 1%
- 32
- Jumlah posisi efektif
- 29,0
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 43,9% Perkiraan pembelian $949.551.903 · penjualan $981.309.950
Kepemilikan median: 2,0 kuartal Dilacak Q4 2024–Q2 2026 · 44,4% masih dipegang
- Posisi baru
- 25
- Meningkat
- 18
- Menurun
- 19
- Tertutup
- 20
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
- Terkait Orang di balik pengaju ini, jika kami dapat mencocokkannya.
Kinerja vs S&P 500
Tahunan: +67.9% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 96,2% · Opsi dikecualikan: 6,7%
Rincian sektor
Healthcare
98,4%
Lainnya/Tidak terpetakan
1,6%
Portofolio lengkap 68 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| ERAS Erasca, Inc. - Common Stock | $222.588.000 | 9,58% | 12.150.000 | $42.181.000 | Naik ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $136.458.240 | 5,87% | 1.024.000 | $61.296.990 | Naik ×2 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $131.096.000 | 5,64% | 700.000 | $-63.404.000 | Turun ×1 | ||
| IDYA IDEAYA Biosciences, Inc. - Common Stock | $111.810.000 | 4,81% | 3.000.000 | $-3.144.000 | Turun ×1 | ||
| BNTX BioNTech SE - American Depositary Shares | $94.445.750 | 4,07% | 1.015.000 | ||||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $94.402.000 | 4,06% | 2.200.000 | ||||
| TNGX Tango Therapeutics, Inc. - Common Stock | $89.091.000 | 3,84% | 2.850.000 | $26.331.000 | Turun ×2 | ||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $87.045.400 | 3,75% | 260.000 | $-4.778.750 | Turun ×2 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $78.141.000 | 3,36% | 2.100.000 | $63.867.000 | Naik ×2 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $77.984.000 | 3,36% | 800.000 | $44.416.000 | Naik ×3 | ||
| CGON CG Oncology, Inc. - Common stock | $71.050.000 | 3,06% | 1.000.000 | $32.134.000 | Naik ×2 | ||
| IRON Disc Medicine, Inc. - Common Stock | $63.997.500 | 2,76% | 875.000 | $28.191.100 | Naik ×3 | ||
| MAZE Maze Therapeutics, Inc. - Common Stock | $57.740.400 | 2,49% | 1.935.000 | $20.875.650 | Naik ×2 | ||
| DYN Dyne Therapeutics, Inc. - Common Stock | $56.635.500 | 2,44% | 2.550.000 | $31.253.500 | Naik ×2 | ||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $52.082.250 | 2,24% | 2.675.000 | $24.122.250 | Naik ×1 | ||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $52.046.000 | 2,24% | 5.300.000 | $19.436.500 | Naik ×4 | ||
| DSGN Design Therapeutics, Inc. - Common Stock | $43.410.000 | 1,87% | 3.000.000 | $22.662.000 | Naik ×1 | ||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $40.143.026 | 1,73% | 3.208.875 | $-7.701.300 | |||
| BLTE Belite Bio, Inc - American Depositary Shares | $38.496.250 | 1,66% | 250.000 | Naik ×1 | |||
| ACHV Achieve Life Sciences, Inc. - Common Shares | $35.425.250 | 1,53% | 5.425.000 | Naik ×1 | |||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $35.062.000 | 1,51% | 1.880.000 | $6.430.000 | Turun ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $34.830.000 | 1,50% | 900.000 | ||||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $34.740.000 | 1,50% | 1.000.000 | $26.665.500 | Naik ×1 | ||
| CBIO Crescent Biopharma, Inc. - Common Stock | $34.200.000 | 1,47% | 1.900.000 | $25.336.475 | Naik ×1 | ||
| CMPS COMPASS Pathways Plc - American Depository Shares | $31.837.500 | 1,37% | 2.250.000 | ||||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $28.329.000 | 1,22% | 1.050.000 | Naik ×1 | |||
| REPL Replimune Group, Inc. - Common Stock | $27.675.000 | 1,19% | 2.500.000 | Naik ×1 | |||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $27.162.000 | 1,17% | 450.000 | $994.500 | |||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $26.835.000 | 1,16% | 500.000 | $2.735.000 | |||
| IMVT Immunovant, Inc. - Common Stock | $25.622.450 | 1,10% | 665.000 | $-1.080.550 | Turun ×2 | ||
| JBIO Jade Biosciences, Inc. - Common Stock | $24.997.500 | 1,08% | 1.125.000 | $19.377.500 | Naik ×2 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $23.598.750 | 1,02% | 465.000 | $2.430.750 | Turun ×1 | ||
| MANE Veradermics, Incorporated Common Stock | $22.129.200 | 0,95% | 180.000 | $20.550.450 | Naik ×1 | ||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $21.252.000 | 0,91% | 1.150.000 | $16.773.000 | Naik ×1 | ||
| RCUS Arcus Biosciences, Inc. Common Stock | $20.039.500 | 0,86% | 650.000 | $-5.880.500 | Turun ×1 | ||
| SMMT Summit Therapeutics Inc. - Common Stock | $19.669.500 | 0,85% | 1.350.000 | Naik ×1 | |||
| IMCR Immunocore Holdings plc - American Depositary Shares | $19.050.000 | 0,82% | 600.000 | $-26.175.000 | Turun ×1 | ||
| LBRX LB Pharmaceuticals Inc - Common Stock | $18.986.175 | 0,82% | 585.000 | $-3.577.725 | Turun ×2 | ||
| NERV Minerva Neurosciences, Inc - Common Stock | $18.252.712 | 0,79% | 3.288.777 | $-1.117.663 | Naik ×1 | ||
| SNSE Sensei Biotherapeutics, Inc. - Common Stock | $18.050.500 | 0,78% | 722.020 | $17.104.900 | Naik ×1 | ||
| CRSP CRISPR Therapeutics AG - Common Shares | $16.362.000 | 0,70% | 300.000 | Naik ×1 | |||
| DBVT DBV Technologies S.A. - American Depositary Shares | $15.006.000 | 0,65% | 915.000 | ||||
| Penerbit tidak dikenal (CUSIP: 698955101) | $14.369.250 | 0,62% | 525.000 | Naik ×1 | |||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $13.878.750 | 0,60% | 125.000 | $-25.257.750 | Turun ×1 | ||
| VOR Vor Biopharma Inc. - Common Stock | $11.966.500 | 0,52% | 650.000 | $-1.413.500 | Turun ×1 | ||
| SRRK Scholar Rock Holding Corporation - Common Stock | $11.000.000 | 0,47% | 200.000 | ||||
| IMMX Immix Biopharma, Inc. - Common Stock | $10.310.000 | 0,44% | 1.000.000 | $-849.750 | Turun ×1 | ||
| QTTB Q32 Bio Inc. - Common Stock | $10.192.000 | 0,44% | 800.000 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 67613T104) | $9.761.681 | 0,42% | 521.736 | Naik ×1 | |||
| ANNX Annexon, Inc. - common stock | $8.565.000 | 0,37% | 1.500.000 | ||||
| EDIT Editas Medicine, Inc. - Common Stock | $7.199.280 | 0,31% | 2.222.000 | Naik ×1 | |||
| RLAY Relay Therapeutics, Inc. - Common Stock | $6.548.500 | 0,28% | 350.000 | $-914.000 | Turun ×1 | ||
| ACAD ACADIA Pharmaceuticals Inc. - Common Stock | $6.325.000 | 0,27% | 250.000 | $-10.370.000 | Turun ×2 | ||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $6.286.000 | 0,27% | 350.000 | $-3.444.000 | Turun ×3 | ||
| HELP Cybin Inc. - Common Stock | $4.957.500 | 0,21% | 750.000 | Naik ×1 | |||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $4.395.179 | 0,19% | 963.855 | Naik ×1 | |||
| TENX Tenax Therapeutics, Inc. - Common Stock | $4.365.000 | 0,19% | 300.000 | $-5.628.750 | Turun ×1 | ||
| DFTX Definium Therapeutics, Inc. - Common Shares | $3.763.200 | 0,16% | 80.000 | Naik ×1 | |||
| UNCY Unicycive Therapeutics, Inc. - Common Stock | $2.221.010 | 0,10% | 473.563 | $-895.035 | |||
| PTN Palatin Technologies, Inc. - Common Stock | $1.402.700 | 0,06% | 130.000 | $-1.036.100 | Turun ×1 | ||
| QURE uniQure N.V. - Ordinary Shares | $1.381.800 | 0,06% | 30.000 | ||||
| Penerbit tidak dikenal (CUSIP: G50765109) | $1.136.000 | 0,05% | 100.000 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: G75226103) | $1.070.000 | 0,05% | 100.000 | Naik ×1 | |||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $1.058.000 | 0,05% | 200.000 | $-817.000 | Turun ×5 | ||
| LGVN Longeveron Inc. - Class A Common stock | $904.761 | 0,04% | 1.287.000 | Naik ×1 | |||
| GUTS Fractyl Health, Inc. - Common Stock | $794.400 | 0,03% | 1.000.000 | $336.600 | |||
| SEPN Septerna, Inc. - Common Stock | $788.623 | 0,03% | 23.548 | $222.765 | |||
| Penerbit tidak dikenal (CUSIP: G0375M101) | $508.000 | 0,02% | 50.000 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| BNTX | $94.445.750 | 1.015.000 | 4,07% |
| VERA | $94.402.000 | 2.200.000 | 4,06% |
| BLTE | $38.496.250 | 250.000 | 1,66% |
| ACHV | $35.425.250 | 5.425.000 | 1,53% |
| COGT | $34.830.000 | 900.000 | 1,50% |
| CMPS | $31.837.500 | 2.250.000 | 1,37% |
| MLYS | $28.329.000 | 1.050.000 | 1,22% |
| REPL | $27.675.000 | 2.500.000 | 1,19% |
| SMMT | $19.669.500 | 1.350.000 | 0,85% |
| CRSP | $16.362.000 | 300.000 | 0,70% |
| DBVT | $15.006.000 | 915.000 | 0,65% |
| Penerbit tidak dikenal (CUSIP: 698955101) | $14.369.250 | 525.000 | 0,62% |
| SRRK | $11.000.000 | 200.000 | 0,47% |
| QTTB | $10.192.000 | 800.000 | 0,44% |
| Penerbit tidak dikenal (CUSIP: 67613T104) | $9.761.681 | 521.736 | 0,42% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| RVMD | Dipangkas | -1.3M | -$63.4M |
| ABVX | Beli lebih banyak | +349K | +$61.3M |
| DNTH | Beli lebih banyak | +400K | +$44.4M |
| ERAS | Beli lebih banyak | +1.0M | +$42.2M |
| CGON | Beli lebih banyak | +425K | +$32.1M |
| DYN | Beli lebih banyak | +1.1M | +$31.3M |
| IRON | Beli lebih banyak | +315K | +$28.2M |
| AVBP | Beli lebih banyak | +650K | +$26.7M |
| TNGX | Dipangkas | -150K | +$26.3M |
| IMCR | Dipangkas | -900K | -$26.2M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| TERN | 30 Juni 2026 | 2.000.000 | $105.440.000 | Tidak lagi dilacak |
| CNTA | 30 Juni 2026 | 2.125.000 | $84.405.000 | Tidak lagi dilacak |
| XBI | 30 Sep. 2025 | 1.000.000 | $82.930.000 | Tidak lagi dilacak |
| CDTX | 31 Maret 2026 | 310.000 | $68.475.900 | Tidak lagi dilacak |
| CYTK | 30 Juni 2026 | 875.000 | $57.671.250 | -10,0% |
| AKRO | 31 Des. 2025 | 1.200.000 | $56.976.000 | Tidak lagi dilacak |
| ARVN | 31 Des. 2025 | 5.575.000 | $47.499.000 | -19,1% |
| UTHR | 30 Juni 2026 | 80.000 | $47.438.400 | -1,5% |
| MDGL | 30 Juni 2026 | 85.000 | $44.494.950 | -0,4% |
| CYTK | 31 Maret 2025 | 900.000 | $42.336.000 | 90,8% |
| VERA | 31 Maret 2025 | 875.000 | $37.003.750 | 37,4% |
| BIIB | 30 Juni 2026 | 200.000 | $36.666.000 | 1,2% |
| RNA | 31 Maret 2026 | 500.000 | $36.065.000 | -1,6% |
| NUVL | 30 Juni 2025 | 500.000 | $35.460.000 | Tidak lagi dilacak |
| JAZZ | 31 Maret 2026 | 200.000 | $34.000.000 | 34,9% |
| TYRA | 30 Juni 2026 | 850.000 | $32.555.000 | -16,9% |
| MRUS | 31 Maret 2025 | 750.000 | $31.537.500 | Tidak lagi dilacak |
| INSM | 31 Maret 2025 | 450.000 | $31.068.000 | 68,8% |
| NBIX | 31 Maret 2025 | 200.000 | $27.300.000 | 40,6% |
| TEVA | 30 Sep. 2025 | 1.500.000 | $25.140.000 | 85,2% |
| APLS | 31 Maret 2026 | 1.000.000 | $25.120.000 | Tidak lagi dilacak |
| PCVX | 31 Maret 2025 | 300.000 | $24.558.000 | 64,8% |
| UTHR | 30 Sep. 2025 | 85.000 | $24.424.750 | 27,3% |
| XENE | 30 Juni 2025 | 650.000 | $21.807.500 | 104,3% |
| JAZZ | 31 Maret 2025 | 175.000 | $21.551.250 | 105,3% |
| PTGX | 31 Des. 2025 | 300.000 | $19.929.000 | 80,5% |
| NAMS | 30 Juni 2026 | 600.000 | $19.206.000 | -17,9% |
| NBIX | 30 Sep. 2025 | 150.000 | $18.853.500 | 10,8% |
| MIRM | 30 Juni 2026 | 200.000 | $18.476.000 | -12,4% |
| BNTX | 30 Juni 2025 | 200.000 | $18.212.000 | 5,9% |
| ETNB | 30 Juni 2025 | 2.500.000 | $18.175.000 | Tidak lagi dilacak |
| SLNO | 30 Juni 2025 | 250.000 | $17.862.500 | Tidak lagi dilacak |
| BPMC | 31 Maret 2025 | 200.000 | $17.444.000 | Tidak lagi dilacak |
| PCVX | 30 Juni 2026 | 300.000 | $17.433.000 | 7,1% |
| TVTX | 31 Maret 2025 | 1.000.000 | $17.420.000 | 262,2% |
| CMPX | 30 Juni 2026 | 3.150.000 | $16.663.500 | 13,5% |
| QURE | 31 Maret 2026 | 675.000 | $16.152.750 | 188,6% |
| APLS | 31 Maret 2025 | 500.000 | $15.955.000 | Tidak lagi dilacak |
| MDGL | 30 Sep. 2025 | 50.000 | $15.132.000 | 16,7% |
| KNSA | 31 Maret 2026 | 350.000 | $14.437.500 | 67,4% |
| ALKS | 31 Maret 2025 | 500.000 | $14.380.000 | 53,5% |
| JANX | 30 Juni 2026 | 1.000.000 | $13.900.000 | 12,6% |
| KRYS | 30 Sep. 2025 | 100.000 | $13.746.000 | 91,4% |
| APGE | 31 Maret 2025 | 300.000 | $13.590.000 | 260,8% |
| KROS | 31 Des. 2025 | 850.000 | $13.447.000 | -46,7% |
| ARVN | 31 Maret 2025 | 700.000 | $13.419.000 | 36,6% |
| GERN | 30 Juni 2025 | 8.000.000 | $12.720.000 | 11,7% |
| ALKS | 30 Juni 2026 | 350.000 | $12.376.000 | -3,3% |
| CLDX | 30 Sep. 2025 | 600.000 | $12.210.000 | 62,2% |
| ORIC | 30 Juni 2026 | 950.000 | $12.036.500 | 32,5% |
| CRNX | 30 Juni 2025 | 350.000 | $11.739.000 | 194,7% |
| SYRE | 31 Maret 2025 | 500.000 | $11.640.000 | 554,7% |
| EWTX | 31 Maret 2025 | 400.000 | $10.680.000 | 110,1% |
| KYMR | 31 Maret 2026 | 130.000 | $10.115.300 | 49,0% |
| PLRX | 31 Maret 2025 | 750.000 | $9.877.500 | -12,2% |
| BHVN | 30 Sep. 2025 | 700.000 | $9.877.000 | -4,3% |
| XNCR | 30 Sep. 2025 | 1.250.000 | $9.825.000 | 125,9% |
| NRIX | 31 Maret 2026 | 500.000 | $9.485.000 | 77,4% |
| MLTX | 30 Sep. 2025 | 200.000 | $9.440.000 | 129,3% |
| IMTX | 31 Maret 2026 | 850.000 | $8.925.000 | -6,2% |
| LEGN | 30 Sep. 2025 | 250.000 | $8.872.500 | -30,5% |
| DRUG | 31 Maret 2025 | 245.000 | $8.824.900 | 136,6% |
| SLNO | 30 Juni 2026 | 250.000 | $8.370.000 | Tidak lagi dilacak |
| LRMR | 31 Des. 2025 | 2.500.000 | $8.075.000 | 11,9% |
| YMAB | 31 Maret 2025 | 1.000.000 | $7.830.000 | Tidak lagi dilacak |
| ACLX | 31 Maret 2026 | 115.000 | $7.498.000 | Tidak lagi dilacak |
| COGT | 31 Des. 2025 | 500.000 | $7.180.000 | 5,9% |
| IMRX | 31 Des. 2025 | 950.000 | $6.650.000 | -20,7% |
| CRVS | 30 Juni 2026 | 450.000 | $6.583.500 | 3,9% |
| SRRK | 31 Des. 2025 | 175.000 | $6.517.000 | 25,4% |
| MGTX | 30 Juni 2026 | 700.000 | $6.062.000 | 5,8% |
| ANNX | 30 Sep. 2025 | 2.410.000 | $5.784.000 | 81,5% |
| CMPS | 30 Juni 2025 | 2.000.000 | $5.720.000 | 397,9% |
| MTSR | 30 Sep. 2025 | 200.000 | $5.690.000 | Tidak lagi dilacak |
| EPRX | 31 Des. 2025 | 900.000 | $5.310.000 | -8,3% |
| VSTM | 30 Juni 2026 | 1.000.000 | $5.300.000 | 96,6% |
| NGNE | 31 Maret 2026 | 195.000 | $4.017.000 | 85,0% |
| BCAX | 30 Sep. 2025 | 400.000 | $3.716.000 | 65,7% |
| ATXS | 31 Des. 2025 | 500.000 | $3.640.000 | Tidak lagi dilacak |
| ATYR | 31 Maret 2025 | 1.000.000 | $3.620.000 | -82,5% |
| AVTE | 30 Juni 2025 | 1.400.000 | $3.514.000 | Tidak lagi dilacak |
| PEPG | 31 Des. 2025 | 750.000 | $3.465.000 | -55,5% |
| DAWN | 31 Maret 2026 | 300.000 | $2.796.000 | Tidak lagi dilacak |
| IBIO | 30 Juni 2026 | 1.300.000 | $2.470.000 | -17,1% |
| RAPP | 30 Sep. 2025 | 208.910 | $2.375.307 | 66,0% |
| ESPR | 31 Des. 2025 | 750.000 | $1.987.500 | Tidak lagi dilacak |
| PHVS | 30 Juni 2026 | 65.000 | $1.836.250 | 4,5% |
| ALEC | 31 Des. 2025 | 500.000 | $1.480.000 | 44,6% |
| GLYC | 30 Juni 2025 | 5.400.000 | $1.134.000 | Tidak lagi dilacak |
| MREO | 31 Maret 2026 | 1.850.000 | $770.895 | -7,1% |
| ALLK | 30 Juni 2025 | 2.900.000 | $660.040 | Tidak lagi dilacak |
| DBVT | 31 Maret 2026 | 25.000 | $479.250 | -29,0% |
| ARTV | 30 Juni 2025 | 145.089 | $435.267 | 643,9% |
| SLDB | 30 Juni 2025 | 100.000 | $370.000 | 99,3% |
| NUVBWS | 31 Maret 2026 | 66.666 | $22.000 | Tidak lagi dilacak |